Fundz

TelyRx Holdings Inc. Appoints Benjamin Atkins as Interim Chief Executive Officer

PUBLIC · TELYFNov 12, 2026
Internal move“Benjamin Atkins, a co-founder of the Company and a member of its Board”

Position

Chief Executive Officer

Company

TelyRx

Benjamin Atkins
Information TechnologyHealth CareMedical

Description

TelyRx Holdings Inc. has appointed Benjamin Atkins as Interim Chief Executive Officer and President, effective immediately. He succeeds Vanessa Slowey, who is stepping down for other commitments

Quick answer

TelyRx Holdings Inc. Appoints Benjamin Atkins as Interim Chief Executive Officer (November 12, 2026).

Who is the new Chief Executive Officer at TelyRx?
TelyRx named Benjamin Atkins Chief Executive Officer, announced November 12, 2026.
What did TelyRx announce on November 12, 2026?
TelyRx Holdings Inc. has appointed Benjamin Atkins as Interim Chief Executive Officer and President, effective immediately.
What does TelyRx do?
TelyRx, Inc. is a vertically integrated technology-enabled healthcare and pharmacy services company.
Which similar companies made leadership changes around the same time?
Profound Medical (November 12, 2026), ConvaTec Group Plc (November 12, 2026), Great Ormond Street Hospital (November 12, 2026) and Actall Corporation (November 10, 2026) also announced leadership changes within 45 days of TelyRx.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at TelyRx, and when

A new leader at TelyRx brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day TelyRx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TelyRx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TelyRx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TelyRx

About

TelyRx, Inc. is a vertically integrated technology-enabled healthcare and pharmacy services company. It focuses on delivering innovative healthcare solutions and enhancing patient care through efficient pharmacy services. The company aims to improve healthcare outcomes and streamline medication management.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TelyRx changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for TelyRx's next move

Learn about Strategic plan

TelyRx changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.